FIELD: biotechnology.
SUBSTANCE: following is presented: an anti-CD79b antibody or antigen-binding fragment thereof, a drug conjugate thereof, and their use. The following is also disclosed: a pharmaceutical composition for treating or preventing a disease, a nucleic acid, an expression vector, a cloning vector, a set for treating or preventing a disease mediated by CD79b.
EFFECT: invention makes it possible to use it for the treatment or prevention of a disease mediated by CD79b, as well as in the manufacture of a diagnostic agent for a cell proliferative disorder associated with increased expression of CD79b.
20 cl, 7 dwg, 14 tbl, 7 ex
Title |
Year |
Author |
Number |
ANTI-CD79B ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF AND PHARMACEUTICAL USE THEREOF |
2020 |
- Yan, Tsujtsin
- Tan, Zhenkhun
|
RU2817143C2 |
ANTI-CD79B ANTIBODIES, IMMUNOCONJUGATES AND METHODS FOR THEIR USE |
2019 |
- Chen, Yvonne
- Dennis, Mark
- Dornan, David
- Elkins, Kristi
- Junutula, Jagath, Reddy
- Polson, Andrew
- Zheng, Bing
|
RU2791984C2 |
TUMOR-TARGETED AGONISTIC CD28-ANTIGEN-BINDING MOLECULES |
2019 |
- George Guy
- Hofer Thomas
- Hosse Ralf
- Klein Christian
- Moessner Ekkehard
- Sam Johannes
- Umana Pablo
- Thom Jenny Tosca
- Gasser Stephan
- Vallier Jean-Baptiste Pierre
- Fauti Tanja
|
RU2808030C2 |
METHODS FOR USING CD32B x CD79B-BINDING MOLECULES IN TREATMENT OF INFLAMMATORY DISEASES AND DISORDERS |
2017 |
- Chen Vej
- Mur Pol A.
- Pandya Naimish Bkharat
- Bonvini Ezio
- Vigginton Dzhon Mark
|
RU2772434C2 |
BISPECIFIC ANTIBODY AGAINST RABIES VIRUS AND ITS APPLICATION |
2019 |
- Liu Zhigang
- Hao Xiaobo
- Liu Yulan
- Guo Jingjing
|
RU2764740C1 |
AMATOXIN ANTIBODY-DRUG CONJUGATES AND USE THEREOF |
2020 |
- Makdonakh, Sharlott Fenton
- Panvar, Radzhiv
- Khekhler, Torsten
- Kulke, Mikhael
- Sarma, Ganapati N.
- Pal, Andreas
- Myuller, Kristof
- Simon, Verner
- Lutts, Kristian
- Gallo, Francheska
|
RU2826004C2 |
RECOVERED ANTIBODY (VERSIONS), A METHOD FOR PRODUCING THE ANTIBODY, AN ISOLATED NUCLEIC ACID, AN EXPRESSION CASSETTE (VERSIONS), A PLASMID (VERSIONS), A HOST CELL, A PHARMACEUTICAL PREPARATION, A KIT, A METHOD OF TREATING A PATIENT, AT RISK OF OR SUFFERING FROM ESCHERICHIA COLI INFECTION, AND A DIAGNOSTIC TECHNIQUE FOR DETERMINING ESCHERICHIA COLI INFECTIONS |
2014 |
- Vaskes Maksimiliano
- Gvchalya Luis
- Nad Gabor
- Nad Ester
- Sijyarto Valeriya
|
RU2724530C2 |
ANTIBODIES TO MYOSTATIN, POLYPEPTIDES CONTAINING FC-REGION VARIANTS, AND THEIR APPLICATION METHODS |
2016 |
- Kuramoti Tajti
- Igava Tomoyuki
- Katada Khitosi
- Khori Yudzi
|
RU2789884C2 |
BCMA-TARGETED ANTIBODY AND ITS USE |
2018 |
- Van, Pen
- Van, Khuamao
- Tszyan, Khua
|
RU2799655C2 |
PHARMACEUTICAL COMPOSITION, INCLUDING A PH20 VARIANT OF HUMAN HYALURONIDASE, AND A MEDICINAL PRODUCT FOR SUBCUTANEOUS ADMINISTRATION |
2020 |
- Park, Soon Jae
- Chung, Hye-Shin
- Lee, Seung Joo
- Kim, Kyuwan
- Byun, Minsoo
- Nam, Ki Seok
|
RU2810952C2 |